- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04816552
Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change (CHoBI7)
April 4, 2024 updated by: Johns Hopkins Bloomberg School of Public Health
Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change (CHoBI7 Program)
Develop a scalable approach for delivering water, sanitation, and hygiene (WASH) messages to households in areas with confirmed cholera patients in Dhaka, Bangladesh.
This will be done by conducting formative research through in-depth interviews, focus group discussions, and intervention planning workshops with households in areas with confirmed cholera patients and government officials to identify perceptions of WASH behaviors and to inform the development of a mobile health intervention (mHealth) for this population.
This intervention approach will then be piloted in a subset of households, and revised according to feedback.
Then the investigators will conduct a randomized controlled of the refined mHealth intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Aim 1. Develop an evidence and theory based WASH mHealth intervention for households in areas with confirmed cholera patients in Dhaka, Bangladesh through formative research
- Conduct formative research through in-depth interviews, focus group discussions, and intervention planning workshops with caregivers and household members of young children, and government officials to identify perceptions of WASH behaviors and to inform the development of intervention materials.
- Pilot the WASH mHealth intervention in a subset of households, and revise according to feedback.
Aim 2: Evaluate the effectiveness of the developed WASH mHealth intervention in increasing WASH behaviors and reducing fecal contamination on hands and in stored drinking water by conducting a RCT
- Recruit and prospectively follow for 12 months 120 households (600 participants, 4 per household) with a child under five years of age assigned to one of two study arms (60 households per arm). The first arm will receive the CHoBI7 mHealth program (CHoBI7 mHealth program Arm) and the second arm will serve as a Control Arm and only receive a general message on oral rehydration solution (ORS).
- Compare the 2 study arms using structured observation of handwashing with soap at stool and food related events, unannounced spot checks of the presence of soap in the cooking and latrine areas of the household, and fecal coliform counts on caregiver hands and in stored drinking water.
Study Type
Interventional
Enrollment (Actual)
284
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dhaka, Bangladesh
- International Centre for Diarrhoeal Disease Research, Bangladesh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- At least one household member must report ownership of an active mobile phone in their possession on the day of enrollment
Exclusion Criteria:
- Household has a tap or basin with running water inside their home.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CHoBI7 mHealth program Arm
The first arm will receive the CHoBI7 mHealth program and a general message on oral rehydration solution (ORS) (CHoBI7 mHealth program Arm) .
|
We will start delivery of this intervention with a pictorial module delivered in the home during two 30 minute visits on cholera transmission and prevention after enrollment.
Households will be provided a handwashing station, a covered water vessel, and chlorine tablets.
Households will then receive the CHoBI7 WASH mHealth program voice and text messages on handwashing with soap and water treatment bi-weekly.
general message on oral rehydration solution (ORS)
|
|
Active Comparator: Standard Recommendation Arm
The second arm will serve as a Control Arm and only receive a general message on oral rehydration solution (ORS).
|
general message on oral rehydration solution (ORS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants That Reported Handwashing With Soap at Stool and Food Related Events
Time Frame: 1 month, 3 months
|
Handwashing with soap measured by 5-hour structured at the following food and stool related events in the household: (1) after using the toilet; (2) after cleaning a child's anus; (3) before eating; (4) before feeding a child; and (5) before preparing food.
|
1 month, 3 months
|
|
Post Intervention Chlorine Concentration in Drinking Water
Time Frame: 7 Days after enrollment
|
Free available chlorine in stored household drinking water >0.2 mg/L
|
7 Days after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Diarrheal Events
Time Frame: Up to 3 months
|
Participants will be asked if they have had diarrhea in the past week at the follow-up visits during the 3 month surveillance visit.
Percentage of diarrheal events is reported.
|
Up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christine Marie George, PhD, Johns Hopkins Bloomberg School of Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2021
Primary Completion (Actual)
November 28, 2021
Study Completion (Actual)
November 28, 2021
Study Registration Dates
First Submitted
March 24, 2021
First Submitted That Met QC Criteria
March 24, 2021
First Posted (Actual)
March 25, 2021
Study Record Updates
Last Update Posted (Actual)
May 2, 2024
Last Update Submitted That Met QC Criteria
April 4, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9255
- IRB00009255 (Other Identifier: JHSPH IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholera
-
International Vaccine InstituteMassachusetts General Hospital; EuBiologics Co.,LtdRecruiting
-
International Vaccine InstituteMedical Research Council, South Africa; BioVacRecruitingCholera VaccinationSouth Africa
-
International Vaccine InstituteNot yet recruitingCholera Vaccination ReactionSweden
-
Albert B. Sabin Vaccine InstituteMassachusetts General Hospital; Washington State University; Kenya Medical Research... and other collaboratorsRecruiting
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A....CompletedCholera Vaccination Reaction | Adverse Reaction to Cholera VaccineCameroon
-
Brigham and Women's HospitalRecruitingCholera | Cholera Vaccine ToxicityUnited States
-
Bavarian NordicEmergent BioSolutionsCompleted
-
Centre for Infectious Disease Research in ZambiaNot yet recruitingCholera Vaccination ReactionZambia
-
International Vaccine InstituteMassachusetts General Hospital; EuBiologics Co.,LtdCompletedCholera Vaccination ReactionKorea, Republic of
Clinical Trials on CHoBI7 mHealth program Arm
-
Johns Hopkins Bloomberg School of Public HealthInternational Centre for Diarrhoeal Disease Research, BangladeshCompletedDiarrhea | Cholera | Stunting
-
Johns Hopkins Bloomberg School of Public HealthUniversity of New Mexico; Wellcome Sanger InstituteRecruitingCholera | Diarrhea Infectious | Water-Related DiseasesDemocratic Republic of the Congo
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID); GiveWell; Research...RecruitingCholera | Diarrhea InfectiousBangladesh
-
Chang Gung Memorial HospitalCompleted
-
Mackay Medical CollegeCompletedOverweight and Obese Pregnant WomenTaiwan
-
The Hong Kong Polytechnic UniversityCompleted
-
Universidad Autonoma de MadridUniversidad Rey Juan CarlosNot yet recruitingFibromyalgia (FM)
-
Chinese University of Hong KongNot yet recruitingMetabolic Syndrome
-
University of TorontoRecruitingSocial Skills | Financial Stress | Social FunctioningUganda
-
Boston University Charles River CampusWashington University School of MedicineCompletedParkinson DiseaseUnited States